Find Cefpodoxime Proxetil manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

184RELATED EXCIPIENT COMPANIES

291EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Vantin, Banan, 87239-81-4, Orelox, Doxef, Cs-807
Molecular Formula
C21H27N5O9S2
Molecular Weight
557.6  g/mol
InChI Key
LTINZAODLRIQIX-FBXRGJNPSA-N
FDA UNII
2TB00A1Z7N

Cefpodoxime Proxetil
Cefpodoxime Proxetil is a third generation semi-synthetic cephalosporin and a beta-lactam antibiotic with bactericidal activity. Cefpodoxime's effect is dependent on its binding to penicillin-binding proteins (PBPs) located in the bacterial cytoplasmic membrane. Binding results in the inhibition of the transpeptidase enzymes, thereby preventing cross-linking of the pentaglycine bridge with the fourth residue of the pentapeptide and interrupting consequent synthesis of peptidoglycan chains. As a result, cefpodoxime inhibits bacterial septum and cell wall synthesis formation.
1 2D Structure

Cefpodoxime Proxetil

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
2.1.2 InChI
InChI=1S/C21H27N5O9S2/c1-9(2)33-21(30)35-10(3)34-19(29)15-11(6-31-4)7-36-18-14(17(28)26(15)18)24-16(27)13(25-32-5)12-8-37-20(22)23-12/h8-10,14,18H,6-7H2,1-5H3,(H2,22,23)(H,24,27)/b25-13-/t10?,14-,18-/m1/s1
2.1.3 InChI Key
LTINZAODLRIQIX-FBXRGJNPSA-N
2.1.4 Canonical SMILES
CC(C)OC(=O)OC(C)OC(=O)C1=C(CSC2N1C(=O)C2NC(=O)C(=NOC)C3=CSC(=N3)N)COC
2.1.5 Isomeric SMILES
CC(C)OC(=O)OC(C)OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\OC)/C3=CSC(=N3)N)COC
2.2 Other Identifiers
2.2.1 UNII
2TB00A1Z7N
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(isopropoxycarbonyloxy)ethyl-7-(2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido)-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo(4,2,0)-oct-2-ene-2-carboxylate

2. Cephalosporin 807

3. Cs 807

4. Cs-807

5. Doxef

6. U 76252

7. U-76,252

8. Vantin

2.3.2 Depositor-Supplied Synonyms

1. Vantin

2. Banan

3. 87239-81-4

4. Orelox

5. Doxef

6. Cs-807

7. Simplicef

8. Otreon

9. U-76252

10. Podomexef

11. Chebi:3505

12. 2tb00a1z7n

13. Cefodox

14. Nsc-759161

15. (rs)-1-((isopropoxycarbonyl)oxy)ethyl (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-((z)-methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate

16. Dsstox_cid_2766

17. Dsstox_rid_76722

18. Cefpodoxime 1-(isopropyloxycarbonyloxy)ethyl Ester

19. Dsstox_gsid_22766

20. Xtum-o

21. 1-{[(propan-2-yloxy)carbonyl]oxy}ethyl (6r,7r)-7-{[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

22. 1-{[(propan-2-yloxy)carbonyl]oxy}ethyl 7beta-[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3,4-didehydrocepham-4-carboxylate

23. Cas-87239-81-4

24. Simplicef [veterinary]

25. Unii-2tb00a1z7n

26. Orelox Paed

27. Ncgc00164598-01

28. Ncgc00183131-01

29. Mfcd00865088

30. Vantin (tn)

31. Cefpodoxime Proxetil [usan:usp:jan]

32. Schembl27071

33. Mls001401428

34. Chembl1201016

35. Dtxsid1022766

36. Cefpodoxime (as Proxetil)

37. Cefpodoxime Proxetil (jp17/usp)

38. Cefpodoxime Proxetil [jan]

39. Hms3715j22

40. Cefpodoxime Proxetil [usan]

41. Cefpodoxime Proxetil, Vantin

42. Hy-n7101

43. Cefpodoxime Proxetil [vandf]

44. Tox21_113377

45. Tox21_113428

46. Bdbm50248233

47. Cefpodoxime Proxetil [mart.]

48. S5350

49. Cefpodoxime Proxetil [usp-rs]

50. Cefpodoxime Proxetil [who-dd]

51. Akos015994692

52. Ccg-221250

53. Ks-1149

54. Nsc 759161

55. Cefpodoxime Proxetil [green Book]

56. (+-)-1-hydroxyethyl (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(z)-(o-methyloxime), Isopropyl Carbonate (ester)

57. Cefpodoxime Proxetil [orange Book]

58. Ru-51807

59. Smr000469193

60. Cefpodoxime Proxetil [ep Monograph]

61. Cefpodoxime Proxetil [usp Impurity]

62. Cefpodoxime Proxetil [usp Monograph]

63. Cefpodoxime Proxetil For Peak Identification

64. Cs-0027614

65. C08115

66. D00920

67. Ab01209734-01

68. 239c814

69. A842048

70. Cefpodoxime Proxetil For Impurity H Identification

71. Cefpodoxime 1-(isopropoxycarbonyloxy)ethyl Ester

72. Cefpodoxime 1-(isopropoxycarbonyloxy)ethyl Ester [mi]

73. (+/-)-1-hydroxyethyl (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7 (sup 2)-(z)-(o-methyloxime), Isopropyl Carbonate (ester)

74. (6r,7r)-1-((isopropoxycarbonyl)oxy)ethyl 7-((z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

75. (6r,7r)-7-(((2z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid 1-(((1-methylethoxy)carbonyl)oxy)ethyl Ester

76. 1-({[(1-methylethyl)oxy]carbonyl}oxy)ethyl (6r,7r)-7-({(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-[(methyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

77. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl Ester, (6r-(6.alpha.,7.beta.(z)))-

78. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl Ester, (6r-(6alpha,7beta(z)))-

79. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, 7-[[(2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, 1-[[(1-methylethoxy)carbonyl]oxy]ethyl Ester, (6r,7r)-

2.4 Create Date
2006-05-03
3 Chemical and Physical Properties
Molecular Weight 557.6 g/mol
Molecular Formula C21H27N5O9S2
XLogP30.6
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count14
Rotatable Bond Count13
Exact Mass557.12501980 g/mol
Monoisotopic Mass557.12501980 g/mol
Topological Polar Surface Area235 Ų
Heavy Atom Count37
Formal Charge0
Complexity976
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameCefpodoxime proxetil
PubMed HealthCefpodoxime Proxetil (By mouth)
Drug ClassesAntibiotic
Drug LabelCefpodoxime proxetil is an orally administered, extended spectrum, semi-synthetic antibiotic of the cephalosporin class. The chemical name is (RS)-1(isopropoxycarbonyloxy) ethyl (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-{(Z)methoxyimino}acetamido]-3-m...
Active IngredientCefpodoxime proxetil
Dosage FormTablet; For suspension
RouteOral
Strengtheq 100mg base; eq 200mg base; eq 100mg base/5ml; eq 50mg base/5ml
Market StatusPrescription
CompanyRanbaxy; Aurobindo Pharma; Sandoz; Orchid Hlthcare

2 of 2  
Drug NameCefpodoxime proxetil
PubMed HealthCefpodoxime Proxetil (By mouth)
Drug ClassesAntibiotic
Drug LabelCefpodoxime proxetil is an orally administered, extended spectrum, semi-synthetic antibiotic of the cephalosporin class. The chemical name is (RS)-1(isopropoxycarbonyloxy) ethyl (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-{(Z)methoxyimino}acetamido]-3-m...
Active IngredientCefpodoxime proxetil
Dosage FormTablet; For suspension
RouteOral
Strengtheq 100mg base; eq 200mg base; eq 100mg base/5ml; eq 50mg base/5ml
Market StatusPrescription
CompanyRanbaxy; Aurobindo Pharma; Sandoz; Orchid Hlthcare

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Cephalosporins [CS]; Cephalosporin Antibacterial [EPC]

API SUPPLIERS

read-more
read-more

01

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

02

HRV Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU arrow-down AUDIT
HRV Global Life Sciences

03

Qilu Antibiotics Pharmaceutical Co...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arvo
Not Confirmed
arrow

Qilu Antibiotics Pharmaceutical Co...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Arvo
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF arrow-down EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT arrow-down
blank

04

Sandoz B2B

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arvo
Not Confirmed
arrow

Sandoz B2B

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Arvo
Not Confirmed
USDMF arrow-down CEP/COS Inactive-api JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT arrow-down
blank

05

Akums Lifesciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arvo
Not Confirmed
arrow

Akums Lifesciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Arvo
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCInactive-api NDC KDMF VMF Others AUDIT
blank

06

Covalent Laboratories Private Limi...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arvo
Not Confirmed
arrow

Covalent Laboratories Private Limi...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Arvo
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCInactive-api NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

07

Orchid Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arvo
Not Confirmed
arrow

Orchid Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Arvo
Not Confirmed
USDMF arrow-down CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

08

Sandoz B2B

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arvo
Not Confirmed
arrow

Sandoz B2B

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Arvo
Not Confirmed
USDMF Inactive-api CEP/COS arrow-down JDMF arrow-down EU-WC NDC KDMF arrow-down VMF Others AUDIT arrow-down
blank

09

Daiichi Sankyo

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arvo
Not Confirmed
arrow

Daiichi Sankyo

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Arvo
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Daiichi Sankyo

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arvo
Not Confirmed
arrow

Daiichi Sankyo

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Arvo
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more
  • Development Update

Details:

Infex (Cefpodoxime) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Sinusitis.


Lead Product(s): Cefpodoxime Proxetil,Inapplicable

Therapeutic Area: Otolaryngology (Ear, Nose, Throat) Brand Name: Infex

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 02, 2018

blank

01

Neutec Ar-Ge San ve Tic A.?

Country
arrow
AOCS Annual Meeting
Not Confirmed

Neutec Ar-Ge San ve Tic A.?

Country
arrow
AOCS Annual Meeting
Not Confirmed

Details : Infex (Cefpodoxime) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Sinusitis.

Product Name : Infex

Product Type : Miscellaneous

Upfront Cash : Inapplicable

November 02, 2018

blank

Details:

ETX0282 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): ETX0282,Cefpodoxime Proxetil

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 09, 2018

blank

02

AOCS Annual Meeting
Not Confirmed
AOCS Annual Meeting
Not Confirmed

Details : ETX0282 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

April 09, 2018

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATE SUPPLIERS

read-more
read-more

01

Arvo
Not Confirmed
arrow
Arvo
Not Confirmed
arrow

CAS Number : 24701-69-7

End Use API : Cefpodoxime Proxetil

About The Company : Hubei Ling Sheng Pharmaceutical Co., Ltd. was established in December 29, 2010, the company is located in Xiangyang City, Hubei Province Xiangcheng Economic Dev...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

EUROAPI

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Flag France
Digital Content Digital Content

Regulatory Info : Deregistered

Registration Country : Sweden

Cefpodoximproxetil

Brand Name : Orelox

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 21-02-1992

Application Number : 1.99E+13

Regulatory Info : Deregistered

Registration Country : Sweden

EUROAPI Compnay Banner

02

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : Orelox

Dosage Form : Cefpodoxime 0.8% 100Ml Oral Use

Dosage Strength : BB os suspe grat 100 ml 40 mg/5 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

03

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : Orelox

Dosage Form : Cefpodoxime 100Mg 12 Combined Oral Use

Dosage Strength : 12 cpr riv 100 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

04

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : Orelox

Dosage Form : Cefpodoxime 200Mg 6 Combined Oral Use

Dosage Strength : 6 cpr riv 200 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

05

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : ORELOX

Dosage Form : Granulate For Oral Suspension

Dosage Strength : 0.80%

Packaging : 100 ML 0.8% - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

06

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : ORELOX

Dosage Form : Film-Coated Tablets

Dosage Strength : 100 mg

Packaging : 12 UNITS 100 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

07

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : ORELOX

Dosage Form : Film-Coated Tablets

Dosage Strength : 200 mg

Packaging : 6 UNITS 200 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

08

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Withdrawn

Registration Country : Malta

Cefpodoxime

Brand Name : Orelox

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 2005-10-12

Application Number :

Regulatory Info : Withdrawn

Registration Country : Malta

Sanofi Company Banner

09

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Withdrawn

Registration Country : Malta

Cefpodoxime

Brand Name : Orelox Children And Infants

Dosage Form : Granule For Oral Suspension

Dosage Strength : 5ML

Packaging :

Approval Date : 2005-09-28

Application Number :

Regulatory Info : Withdrawn

Registration Country : Malta

Sanofi Company Banner

10

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Withdrawn

Registration Country : Malta

Cefpodoxime

Brand Name : Orelox

Dosage Form : Film Coated Tablet

Dosage Strength : 200MG

Packaging :

Approval Date : 2011-05-06

Application Number :

Regulatory Info : Withdrawn

Registration Country : Malta

Sanofi Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Approval Date : 2007-06-11

Application Number : 65370

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

02

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2007-06-11

Application Number : 65370

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

03

CHARTWELL RX

U.S.A
Arvo
Not Confirmed
arrow

CHARTWELL RX

U.S.A
arrow
Arvo
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : EQ 50MG BASE/5ML

Approval Date : 2009-01-14

Application Number : 90031

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

04

CHARTWELL RX

U.S.A
Arvo
Not Confirmed
arrow

CHARTWELL RX

U.S.A
arrow
Arvo
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : EQ 100MG BASE/5ML

Approval Date : 2009-01-14

Application Number : 90031

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

05

SANKYO

Japan
Arvo
Not Confirmed
arrow

SANKYO

Japan
arrow
Arvo
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : BANAN

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Approval Date : 1992-08-07

Application Number : 50687

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

06

SANKYO

Japan
Arvo
Not Confirmed
arrow

SANKYO

Japan
arrow
Arvo
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : BANAN

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 1992-08-07

Application Number : 50687

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

07

PFIZER

U.S.A
Arvo
Not Confirmed
arrow

PFIZER

U.S.A
arrow
Arvo
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : VANTIN

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : EQ 100MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1992-08-07

Application Number : 50675

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

08

SANDOZ

Switzerland
Arvo
Not Confirmed
arrow

SANDOZ

Switzerland
arrow
Arvo
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Approval Date : 2008-05-28

Application Number : 65462

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

09

SANDOZ

Switzerland
Arvo
Not Confirmed
arrow

SANDOZ

Switzerland
arrow
Arvo
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2008-05-28

Application Number : 65462

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

10

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

CEFPODOXIME PROXETIL

Brand Name : CEFPODOXIME PROXETIL

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Approval Date : 2003-08-20

Application Number : 65083

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Flag France
Digital Content Digital Content

Regulatory Info : Deregistered

Registration Country : Sweden

Cefpodoximproxetil

Brand Name : Orelox

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 21-02-1992

Application Number : 1.99E+13

Regulatory Info : Deregistered

Registration Country : Sweden

EUROAPI Compnay Banner

02

SANOFI SpA

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : Orelox

Dosage Form : Cefpodoxime 0.8% 100Ml Oral Use

Dosage Strength : BB os suspe grat 100 ml 40 mg/5 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

03

SANOFI SpA

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : Orelox

Dosage Form : Cefpodoxime 100Mg 12 Combined Oral Use

Dosage Strength : 12 cpr riv 100 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

04

SANOFI SpA

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : Orelox

Dosage Form : Cefpodoxime 200Mg 6 Combined Oral Use

Dosage Strength : 6 cpr riv 200 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

05

SANOFI SRL

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : ORELOX

Dosage Form : Granulate For Oral Suspension

Dosage Strength : 0.80%

Packaging : 100 ML 0.8% - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

06

SANOFI SRL

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : ORELOX

Dosage Form : Film-Coated Tablets

Dosage Strength : 100 mg

Packaging : 12 UNITS 100 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

07

SANOFI SRL

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info :

Registration Country : Italy

Cefpodoxime

Brand Name : ORELOX

Dosage Form : Film-Coated Tablets

Dosage Strength : 200 mg

Packaging : 6 UNITS 200 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

08

Sanofi S.R.L

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Withdrawn

Registration Country : Malta

Cefpodoxime

Brand Name : Orelox

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 2005-10-12

Application Number :

Regulatory Info : Withdrawn

Registration Country : Malta

Sanofi Company Banner

09

Sanofi S.R.L

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Withdrawn

Registration Country : Malta

Cefpodoxime

Brand Name : Orelox Children And Infants

Dosage Form : Granule For Oral Suspension

Dosage Strength : 5ML

Packaging :

Approval Date : 2005-09-28

Application Number :

Regulatory Info : Withdrawn

Registration Country : Malta

Sanofi Company Banner

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Withdrawn

Registration Country : Malta

Cefpodoxime

Brand Name : Orelox

Dosage Form : Film Coated Tablet

Dosage Strength : 200MG

Packaging :

Approval Date : 2011-05-06

Application Number :

Regulatory Info : Withdrawn

Registration Country : Malta

Sanofi Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZeon Pharma is a manufacturer and supplier of APIs & Intermediates.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Cefpodoxime Proxetil

Brand Name : Cefpodoxime Proxetil

Dosage Form : Granules

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Zeon Pharma Industries India Pvt Ltd

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZeon Pharma is a manufacturer and supplier of APIs & Intermediates.

Flag India
Digital Content Digital Content

Packaging :

Regulatory Info :

Cefpodoxime Proxetil

Dosage : Granules

Dosage Strength : 200MG

Brand Name : Cefpodoxime Proxetil

Approval Date :

Application Number :

Registration Country : India

Zeon Pharma Industries India Pvt Ltd

02

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil; Clavulanic Acid

Brand Name : Cefpodoxime;Clavulanic...

Dosage Form : Dry Syrup

Dosage Strength : 100MG; 62.5MG

Packaging : 30ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

02

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil; Clavulanic Acid

Dosage : Dry Syrup

Dosage Strength : 100MG; 62.5MG

Brand Name : Cefpodoxime;Clavulanic...

Approval Date :

Application Number :

Registration Country : India

blank

03

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil

Brand Name :

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

03

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil

Dosage : Tablet

Dosage Strength : 100mg

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

04

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil

Brand Name :

Dosage Form : TABLET

Dosage Strength : 100

Packaging :

Approval Date :

Application Number : 65370

Regulatory Info : Generic

Registration Country : India

blank

04

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil

Dosage : TABLET

Dosage Strength : 100

Brand Name :

Approval Date :

Application Number : 65370

Registration Country : India

blank

05

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil

Brand Name :

Dosage Form : Tablet

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

05

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil

Dosage : Tablet

Dosage Strength : 100MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

06

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime

Brand Name :

Dosage Form : Tablet

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

06

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime

Dosage : Tablet

Dosage Strength : 100MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

07

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil

Brand Name :

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

07

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil

Dosage : TABLET

Dosage Strength : 50MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

08

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil; Clavulanic Acid

Brand Name : Cefpodoxime Proxetil ;...

Dosage Form : Tablet

Dosage Strength : 100 MG ; 62.50 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

08

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil; Clavulanic Acid

Dosage : Tablet

Dosage Strength : 100 MG ; 62.50 MG

Brand Name : Cefpodoxime Proxetil ;...

Approval Date :

Application Number :

Registration Country : India

blank

09

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil

Brand Name :

Dosage Form :  Tablet

Dosage Strength : 200mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

09

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil

Dosage :  Tablet

Dosage Strength : 200mg

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

10

Zeiss Pharma

India
Arvo
Not Confirmed
arrow

Zeiss Pharma

India
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil

Brand Name :

Dosage Form : Tablet

Dosage Strength : 200mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

10

Zeiss Pharma

India
Arvo
Not Confirmed
arrow

Zeiss Pharma

India
arrow
Arvo
Not Confirmed

Cefpodoxime Proxetil

Dosage : Tablet

Dosage Strength : 200mg

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Direct Compression

read-more
read-more

Controlled & Modified Release

read-more
read-more

Lubricants & Glidants

read-more
read-more

Taste Masking

read-more
read-more

Co-Processed Excipients

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

API Stability Enhancers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

Solubilizers

read-more
read-more

Emulsifying Agents

read-more
read-more

Topical

read-more
read-more

Empty Capsules

read-more
read-more

Rheology Modifiers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 87239-81-4 / Cefpodoxime Proxetil API manufacturers, exporters & distributors?

Cefpodoxime Proxetil manufacturers, exporters & distributors 1

16

PharmaCompass offers a list of Cefpodoxime Proxetil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cefpodoxime Proxetil manufacturer or Cefpodoxime Proxetil supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefpodoxime Proxetil manufacturer or Cefpodoxime Proxetil supplier.

API | Excipient name

Cefpodoxime Proxetil

Synonyms

Vantin, Banan, 87239-81-4, Orelox, Doxef, Cs-807

Cas Number

87239-81-4

Unique Ingredient Identifier (UNII)

2TB00A1Z7N

About Cefpodoxime Proxetil

Cefpodoxime Proxetil is a third generation semi-synthetic cephalosporin and a beta-lactam antibiotic with bactericidal activity. Cefpodoxime's effect is dependent on its binding to penicillin-binding proteins (PBPs) located in the bacterial cytoplasmic membrane. Binding results in the inhibition of the transpeptidase enzymes, thereby preventing cross-linking of the pentaglycine bridge with the fourth residue of the pentapeptide and interrupting consequent synthesis of peptidoglycan chains. As a result, cefpodoxime inhibits bacterial septum and cell wall synthesis formation.

Cefpodoximum Manufacturers

A Cefpodoximum manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefpodoximum, including repackagers and relabelers. The FDA regulates Cefpodoximum manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefpodoximum API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Cefpodoximum manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Cefpodoximum Suppliers

A Cefpodoximum supplier is an individual or a company that provides Cefpodoximum active pharmaceutical ingredient (API) or Cefpodoximum finished formulations upon request. The Cefpodoximum suppliers may include Cefpodoximum API manufacturers, exporters, distributors and traders.

click here to find a list of Cefpodoximum suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Cefpodoximum USDMF

A Cefpodoximum DMF (Drug Master File) is a document detailing the whole manufacturing process of Cefpodoximum active pharmaceutical ingredient (API) in detail. Different forms of Cefpodoximum DMFs exist exist since differing nations have different regulations, such as Cefpodoximum USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Cefpodoximum DMF submitted to regulatory agencies in the US is known as a USDMF. Cefpodoximum USDMF includes data on Cefpodoximum's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cefpodoximum USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Cefpodoximum suppliers with USDMF on PharmaCompass.

Cefpodoximum JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Cefpodoximum Drug Master File in Japan (Cefpodoximum JDMF) empowers Cefpodoximum API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Cefpodoximum JDMF during the approval evaluation for pharmaceutical products. At the time of Cefpodoximum JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Cefpodoximum suppliers with JDMF on PharmaCompass.

Cefpodoximum KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Cefpodoximum Drug Master File in Korea (Cefpodoximum KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefpodoximum. The MFDS reviews the Cefpodoximum KDMF as part of the drug registration process and uses the information provided in the Cefpodoximum KDMF to evaluate the safety and efficacy of the drug.

After submitting a Cefpodoximum KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefpodoximum API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Cefpodoximum suppliers with KDMF on PharmaCompass.

Cefpodoximum CEP

A Cefpodoximum CEP of the European Pharmacopoeia monograph is often referred to as a Cefpodoximum Certificate of Suitability (COS). The purpose of a Cefpodoximum CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cefpodoximum EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cefpodoximum to their clients by showing that a Cefpodoximum CEP has been issued for it. The manufacturer submits a Cefpodoximum CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cefpodoximum CEP holder for the record. Additionally, the data presented in the Cefpodoximum CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cefpodoximum DMF.

A Cefpodoximum CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cefpodoximum CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Cefpodoximum suppliers with CEP (COS) on PharmaCompass.

Cefpodoximum WC

A Cefpodoximum written confirmation (Cefpodoximum WC) is an official document issued by a regulatory agency to a Cefpodoximum manufacturer, verifying that the manufacturing facility of a Cefpodoximum active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cefpodoximum APIs or Cefpodoximum finished pharmaceutical products to another nation, regulatory agencies frequently require a Cefpodoximum WC (written confirmation) as part of the regulatory process.

click here to find a list of Cefpodoximum suppliers with Written Confirmation (WC) on PharmaCompass.

Cefpodoximum NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cefpodoximum as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Cefpodoximum API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Cefpodoximum as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Cefpodoximum and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cefpodoximum NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Cefpodoximum suppliers with NDC on PharmaCompass.

Cefpodoximum GMP

Cefpodoximum Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Cefpodoximum GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cefpodoximum GMP manufacturer or Cefpodoximum GMP API supplier for your needs.

Cefpodoximum CoA

A Cefpodoximum CoA (Certificate of Analysis) is a formal document that attests to Cefpodoximum's compliance with Cefpodoximum specifications and serves as a tool for batch-level quality control.

Cefpodoximum CoA mostly includes findings from lab analyses of a specific batch. For each Cefpodoximum CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Cefpodoximum may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefpodoximum EP), Cefpodoximum JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefpodoximum USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty